These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 309464

  • 21. [Rheumatoid disease in children (juvenile rheumatoid arthritis)].
    Alfano G, Ciarma E.
    Pediatria (Napoli); 1981 Mar 31; 89(1):109-43. PubMed ID: 7027163
    [No Abstract] [Full Text] [Related]

  • 22. Direct immunofluorescent findings in scleroderma syndromes.
    Connolly SM, Winkelmann RK.
    Acta Derm Venereol; 1981 Mar 31; 61(1):29-36. PubMed ID: 6164211
    [Abstract] [Full Text] [Related]

  • 23. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
    Fishbein E, Ramos-Niembro F, Alarcon-Segovia D.
    J Rheumatol; 1978 Mar 31; 5(4):384-90. PubMed ID: 310882
    [Abstract] [Full Text] [Related]

  • 24. Mixed connective tissue disease - a subset with sequential clinical and laboratory features.
    Grant KD, Adams LE, Hess EV.
    J Rheumatol; 1981 Mar 31; 8(4):587-98. PubMed ID: 6975376
    [Abstract] [Full Text] [Related]

  • 25. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H, Isenberg DA, Shoenfeld Y, Offen D, Sperling J, Sperling R.
    J Immunol; 1987 Apr 15; 138(8):2463-8. PubMed ID: 3494067
    [Abstract] [Full Text] [Related]

  • 26. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M, Okano Y, Mukohda Y, Sato A, Ito M.
    J Clin Lab Immunol; 1984 Jan 15; 13(1):15-9. PubMed ID: 6609234
    [Abstract] [Full Text] [Related]

  • 27. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP, Beardmore T, Kaufman RL, Mongan ES.
    Clin Exp Immunol; 1983 May 15; 52(2):333-40. PubMed ID: 6602676
    [Abstract] [Full Text] [Related]

  • 28. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A, Krajnc I, Gorenjak M, Holc I.
    Wien Klin Wochenschr; 1998 May 08; 110(9):338-41. PubMed ID: 9629626
    [Abstract] [Full Text] [Related]

  • 29. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan 08; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 30. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
    Benhamou CL, Amor B, Menkes CJ, Delbarre F.
    Ann Med Interne (Paris); 1982 Jan 08; 133(2):72-9. PubMed ID: 6979281
    [Abstract] [Full Text] [Related]

  • 31. [Sharp syndrome complicating pulmonary tuberculosis: apropos of a case].
    Ndiaye M, Hane AA, Dieng MT, Ndir M, Ba O, Cissokho S, Kandji M, Diatta A, Niang A, Ndiaye B.
    Dakar Med; 1999 Jan 08; 44(2):236-9. PubMed ID: 11957293
    [Abstract] [Full Text] [Related]

  • 32. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix.
    Fritzler MJ, Ali R, Tan EM.
    J Immunol; 1984 Mar 08; 132(3):1216-22. PubMed ID: 6198384
    [Abstract] [Full Text] [Related]

  • 33. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
    Kahn MF, Peltier AP, Appelboom T.
    Nouv Presse Med; 1975 Jun 21; 4(25):1863-5. PubMed ID: 1080278
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P, Barrett D, Champlin E.
    Ann Allergy; 1982 Sep 21; 49(3):152-5. PubMed ID: 6981365
    [Abstract] [Full Text] [Related]

  • 35. Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.
    Haroon N, Nisha RS, Chandran V, Bharadwaj A.
    J Postgrad Med; 2005 Sep 21; 51(2):104-7, discussion 107-8. PubMed ID: 16006700
    [Abstract] [Full Text] [Related]

  • 36. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH, Pachman L, Medof ME.
    J Rheumatol; 1981 Sep 21; 8(4):632-4. PubMed ID: 6975377
    [Abstract] [Full Text] [Related]

  • 37. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
    Amigues JM, Cantagrel A, Abbal M, Mazieres B.
    J Rheumatol; 1996 Dec 21; 23(12):2055-62. PubMed ID: 8970041
    [Abstract] [Full Text] [Related]

  • 38. [Clinical evaluation of immuno-serological laboratory data].
    Kasukawa R, Tojo J, Kuwana T, Obara K.
    Rinsho Byori; 1996 Dec 21; 44(12):1157-63. PubMed ID: 8990934
    [Abstract] [Full Text] [Related]

  • 39. Mixed connective tissue disease. Appearance of antibodies to ribonucleoprotein following corticosteroid treatment.
    Alarcon-Segovia D.
    J Rheumatol; 1979 Dec 21; 6(6):694-9. PubMed ID: 529254
    [Abstract] [Full Text] [Related]

  • 40. Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Prevalence of and relation to antibodies against DNA and extractable nuclear antigens.
    Gripenberg M, Piirainen H, Linder E.
    Scand J Rheumatol; 1981 Dec 21; 10(1):33-7. PubMed ID: 6971488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.